Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Dirix

Showing results (101-110 of 195) with videos related to

Pageof 20
Sort By:
Histopathology|June 27, 2007
A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and (lymph)angiogenesis in breast cancer: review of the literature and proposal on the criteria of evaluationG G Van den Eynden, C G Colpaert, A Couvelard, et al.
British Journal of Cancer|February 1, 1995
Microvessel quantification in primary colorectal carcinoma: an immunohistochemical studyP B Vermeulen, D Verhoeven, H Fierens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Microvessel density, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomasP B Vermeulen, D Verhoeven, G Hubens, et al.
The Journal of Pathology|June 1, 1997
Evaluation of tumour angiogenesis as a prognostic marker in malignant mesotheliomaS Kumar-Singh, P B Vermeulen, J Weyler, et al.
British Journal of Cancer|August 19, 2007
NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivationS J Van Laere, I Van der Auwera, G G Van den Eynden, et al.
European Journal of Cancer (Oxford, England : 1990)|July 8, 2000
High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatmentS Kvinnsland, G Anker, L Y Dirix, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2000
Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen. results Of a double-blind randomised phase III trialM Kaufmann, E Bajetta, L Y Dirix, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 16, 2011
VEGF-A-independent and angiogenesis-dependent tumour growth in patients with metastatic breast cancerX Bich Trinh, P A van Dam, P B Vermeulen, et al.
British Journal of Cancer|October 27, 2004
Real-time RT-PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancerI H Benoy, H Elst, I Van der Auwera, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1996
Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluationP B Vermeulen, G Gasparini, S B Fox, et al.
Pageof 20

Showing results (101-110 of 195) with videos related to

Sort By:
Pageof 20
Histopathology|June 27, 2007
A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and (lymph)angiogenesis in breast cancer: review of the literature and proposal on the criteria of evaluationG G Van den Eynden, C G Colpaert, A Couvelard, et al.
British Journal of Cancer|February 1, 1995
Microvessel quantification in primary colorectal carcinoma: an immunohistochemical studyP B Vermeulen, D Verhoeven, H Fierens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Microvessel density, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomasP B Vermeulen, D Verhoeven, G Hubens, et al.
The Journal of Pathology|June 1, 1997
Evaluation of tumour angiogenesis as a prognostic marker in malignant mesotheliomaS Kumar-Singh, P B Vermeulen, J Weyler, et al.
British Journal of Cancer|August 19, 2007
NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivationS J Van Laere, I Van der Auwera, G G Van den Eynden, et al.
European Journal of Cancer (Oxford, England : 1990)|July 8, 2000
High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatmentS Kvinnsland, G Anker, L Y Dirix, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2000
Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen. results Of a double-blind randomised phase III trialM Kaufmann, E Bajetta, L Y Dirix, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 16, 2011
VEGF-A-independent and angiogenesis-dependent tumour growth in patients with metastatic breast cancerX Bich Trinh, P A van Dam, P B Vermeulen, et al.
British Journal of Cancer|October 27, 2004
Real-time RT-PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancerI H Benoy, H Elst, I Van der Auwera, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1996
Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluationP B Vermeulen, G Gasparini, S B Fox, et al.
Pageof 20